SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Syschem (India) - Quaterly Results

15 May 2023 Evaluate
The total revenue hovered 152.73% to Rs. 569.09 millions for the March 2023 quarter as against Rs. 225.18 millions during the corresponding quarter last year.The company suffered a huge decline of -84.41% to Rs. 3.88  millions from Rs. 24.88 millions  of corresponding previous quarter.Operating Profit reported a sharp decline to 25.77 millions from 29.36 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 569.09 225.18 152.73 1303.77 656.33 98.65 1303.77 656.33 98.65
Other Income 0.58 0.63 -7.94 2.48 1.26 96.83 2.48 1.26 96.83
PBIDT 25.77 29.36 -12.23 88.96 6.93 1183.69 88.96 6.93 1183.69
Interest -0.41 2.21 -118.55 0.42 2.84 -85.21 0.42 2.84 -85.21
PBDT 26.18 27.15 -3.57 88.54 4.09 2064.79 88.54 4.09 2064.79
Depreciation 5.92 6.93 -14.57 27.03 25.81 4.73 27.03 25.81 4.73
PBT 20.26 20.22 0.20 61.51 -21.72 -383.20 61.51 -21.72 -383.20
TAX 16.38 -4.66 -451.50 16.38 -4.66 -451.50 16.38 -4.66 -451.50
Deferred Tax 16.38 -4.66 -451.50 16.38 -4.66 -451.50 16.38 -4.66 -451.50
PAT 3.88 24.88 -84.41 45.13 -17.06 -364.54 45.13 -17.06 -364.54
Equity 318.90 232.90 36.93 318.90 232.90 36.93 318.90 232.90 36.93
PBIDTM(%) 4.53 13.04 -65.27 6.82 1.06 546.21 6.82 1.06 546.21

Syschem (India) Share Price

52.87 0.74 (1.42%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×